Page last updated: 2024-10-24

verapamil and Hyperlipemia

verapamil has been researched along with Hyperlipemia in 3 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research Excerpts

ExcerptRelevanceReference
" Further studies in humans are required to determine whether modification of the oral verapamil dosage regimen in HL states is necessary."1.38Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407. ( Kang, HE; Lee, MG; Lee, YS; Yoon, IS; Yoon, JN, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, YS1
Yoon, JN1
Yoon, IS1
Lee, MG1
Kang, HE1
Oganov, RG1
Lepakhin, VK1
Fitilev, SB1
Levin, AM1
Titarova, YY1
Sytchev, EN1
Tilton, GD1
Buja, LM1
Bilheimer, DW1
Apprill, P1
Ashton, J1
McNatt, J1
Kita, T1
Willerson, JT1

Other Studies

3 other studies available for verapamil and Hyperlipemia

ArticleYear
Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407.
    Xenobiotica; the fate of foreign compounds in biological systems, 2012, Volume: 42, Issue:8

    Topics: Administration, Oral; Animals; Blood Proteins; Hyperlipidemias; Infusions, Intravenous; Male; Micros

2012
[Diagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern)].
    Kardiologiia, 2003, Volume: 43, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Angiotens

2003
Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia.
    Journal of the American College of Cardiology, 1985, Volume: 6, Issue:1

    Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Disease Models, Animal; Female; Hyperlipidemias

1985